Nov 10, 2020 / 03:15PM GMT
Erin Wright -
Hi and welcome. This is Erin Wright, the life sciences, tools, diagnostics analyst at Crédit Suisse and welcome to our 2020 Crédit Suisse Health Care Conference. This year, we're obviously in a virtual format, so a little bit different. If you do have any questions, feel free to e-mail me at erin.wright@crédit.suisse.com and I'll be happy to relay questions to you -- to our presenters today.
Here with us, we have Charles River Laboratories. With them, we have Birgit Girshick -- I'm going to get your title right, I swear -- it's EVP, Discovery & Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services, if I have it all there. So it's pretty hard-core at Charles River, it sounds like. But -- and we also have Todd Spencer, the IR maven himself on the line as well. And thank you, thank you so much for joining us today.
It's a fireside chat format, so we'll get started with Q&A right away here.
Questions and Answers:
Erin Wright -I think one of the biggest question areas and one of the biggest, I guess, takeaways,